7KCO
ROR gamma in complex with SCR2 and compound 3
7KCO の概要
エントリーDOI | 10.2210/pdb7kco/pdb |
分子名称 | Nuclear receptor ROR-gamma, Peptide GLU-LYS-HIS-LYS-ILE-LEU-HIS-ARG-LEU-LEU-GLN-ASP-SER, 1-[(2-chlorophenyl)methyl]-N-{[4-(methylsulfonyl)phenyl]methyl}-4',5'-dihydrospiro[piperidine-4,7'-thieno[2,3-c]pyran]-2'-carboxamide, ... (5 entities in total) |
機能のキーワード | inhibitor, signaling protein |
由来する生物種 | Homo sapiens (Human) 詳細 |
タンパク質・核酸の鎖数 | 4 |
化学式量合計 | 62104.97 |
構造登録者 | Durbin, J.D.,Guo, S.Y.,Stout, S.L.,Clawson, D.K. (登録日: 2020-10-06, 公開日: 2021-04-21, 最終更新日: 2024-04-03) |
主引用文献 | Lugar, C.W.,Clarke, C.A.,Morphy, R.,Rudyk, H.,Sapmaz, S.,Stites, R.E.,Vaught, G.M.,Furness, K.,Broughton, H.B.,Durst, G.L.,Clawson, D.K.,Stout, S.L.,Guo, S.Y.,Durbin, J.D.,Stayrook, K.R.,Edmondson, D.D.,Kikly, K.,New, N.E.,Bina, H.A.,Chambers, M.G.,Shetler, P.,Chang, W.Y.,Chang, V.C.,Barr, R.,Gough, W.H.,Steele, J.P.,Getman, B.,Patel, N.,Mathes, B.M.,Richardson, T.I. Defining Target Engagement Required for Efficacy In Vivo at the Retinoic Acid Receptor-Related Orphan Receptor C2 (ROR gamma t). J.Med.Chem., 64:5470-5484, 2021 Cited by PubMed Abstract: The Th17 pathway has been implicated in autoimmune diseases. The retinoic acid receptor-related orphan receptor C2 (RORγt) is a master regulator of Th17 cells and controls the expression of IL-17A. RORγt is expressed primarily in IL-17A-producing lymphoid cells. Here we describe a virtual screen of the ligand-binding pocket and subsequent screen in a binding assay that identified the 1-benzyl-4',5'-dihydrospiro[piperidine-4,7'-thieno[2,3-]pyran]-2'-carboxamide scaffold as a starting point for optimization of binding affinity and functional activity guided by structure-based design. Compound demonstrated activity in a mouse PK/PD model and efficacy in an inflammatory arthritis mouse model that were used to define the level and duration of target engagement required for efficacy . Further optimization to improve ADME and physicochemical properties with guidance from simulations and modeling provided compound , which is projected to achieve the level and duration of target engagement required for efficacy in the clinic. PubMed: 33852312DOI: 10.1021/acs.jmedchem.0c01918 主引用文献が同じPDBエントリー |
実験手法 | X-RAY DIFFRACTION (1.86 Å) |
構造検証レポート
検証レポート(詳細版)をダウンロード